What is Eastman Chemical Company's earnings per share (EPS)?

Eastman Chemical Company (EMN) reported diluted earnings per share of $4.10 for fiscal year 2025. This represents a -46.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Eastman Chemical Company (EMN) Financials

EMN

Trailing 12 months to June 30, 2026

Revenue $8.9B -4.5% YoY

Net Income $442.0M -46.9% YoY

EPS (Diluted) $3.84 -46.0% YoY

Free Cash Flow $539.0M +32.8% YoY

Market Cap $7.4B as of Oct 6, 2026

Price / Sales 0.8x on $8.9B revenue, trailing 12 months to June 30, 2026

Price / Earnings 16.8x on $442.0M net income, trailing 12 months to June 30, 2026

Price / Book 1.2x on $6.1B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 6, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 31, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 31, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the EMN SEC filings page.

Eastman Chemical Company (EMN) reported $8.9B in revenue over the twelve months to Jun 30, 2026, down 4.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI EMN FY2025 2026-10-03

Eastman’s 2025 downturn reached profits through weaker margins, while cash generation and lower leverage softened the balance-sheet impact.

Cash conversion diverged from earnings: operating cash flow was 2.0x net income in FY2025, showing profits were depressed more than cash generation; however, capital spending absorbed 56.3% of operating cash flow. Free cash flow was only $424M, indicating that reinvestment consumed much of the internally generated cash despite the stronger operating-cash figure.

Margin compression, not overhead growth, drove the earnings decline: gross margin fell from 24.4% in FY2024 to 21.1% in FY2025 while selling, general and administrative expense declined. Revenue fell 6.7%, but net margin dropped to 5.4%, so the smaller top line translated into a disproportionately larger profit reduction.

The balance sheet became less leveraged during the weaker year: debt-to-equity eased from 0.8x in FY2024 to 0.7x in FY2025 while total liabilities decreased and equity increased. A current ratio of 1.4x indicates current assets exceeded near-term obligations, giving the company a more measured financing posture even as profitability weakened.

Financial Health Signals

Financial Health Score 27/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Eastman Chemical Company's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Not available for Eastman Chemical Company, and counted as zero in the overall score.

Growth

Eastman Chemical Company's revenue declined 6.7% year-over-year, from $9.4B to $8.8B. This contraction results in a growth score of 22/100.

Leverage

Eastman Chemical Company has a moderate D/E ratio of 0.70. This balance of debt and equity financing earns a leverage score of 54/100.

Liquidity

Eastman Chemical Company's current ratio of 1.37 indicates adequate short-term liquidity, earning a score of 37/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Eastman Chemical Company has a free cash flow margin of 4.8%, earning a moderate score of 49/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Not available for Eastman Chemical Company, and counted as zero in the overall score.

Piotroski F-Score Neutral

5/9

Eastman Chemical Company passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

2.05x

For every $1 of reported earnings, Eastman Chemical Company generates $2.05 in operating cash flow ($970.0M OCF vs $474.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.5B

YoY+9.9%

QoQ+15.4%

5Y CAGR-1.1%

10Y CAGR+0.9%

Eastman Chemical Company generated $2.5B in revenue in Q2 2026. This represents an increase of 9.9% from the same quarter a year earlier. Against the prior quarter it is up 15.4%.

Net Income

$183.0M

YoY+30.7%

QoQ+71.0%

10Y CAGR-3.3%

Eastman Chemical Company reported $183.0M in net income in Q2 2026. This represents an increase of 30.7% from the same quarter a year earlier. Against the prior quarter it is up 71.0%.

EPS (Diluted)

$1.59

YoY+32.5%

QoQ+71.0%

10Y CAGR-0.7%

Eastman Chemical Company earned $1.59 per diluted share (EPS) in Q2 2026. This represents an increase of 32.5% from the same quarter a year earlier. Against the prior quarter it is up 71.0%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow

$124.0M

YoY+49.4%

QoQ+151.7%

5Y CAGR-17.2%

10Y CAGR-10.4%

Eastman Chemical Company generated $124.0M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 49.4% from the same quarter a year earlier. Against the prior quarter it is up 151.7%.

Cash & Debt

$691.0M

YoY+63.4%

QoQ+3.9%

5Y CAGR+2.6%

10Y CAGR+11.2%

Eastman Chemical Company held $691.0M in cash against $4.5B in long-term debt as of Q2 2026.

Dividends Per Share

$0.84

YoY+1.2%

QoQ0.0%

5Y CAGR+4.0%

10Y CAGR+6.2%

Eastman Chemical Company paid $0.84 per share in dividends in Q2 2026. This represents an increase of 1.2% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

114M

YoY-0.4%

QoQ0.0%

5Y CAGR-3.4%

10Y CAGR-2.5%

Eastman Chemical Company had 114M shares outstanding in Q2 2026. This represents a decrease of 0.4% from the same quarter a year earlier. It is unchanged from the prior quarter.

Margins & Returns

Gross Margin

22.3%

YoY+0.2pp

QoQ+2.5pp

5Y change-3.4pp

10Y change-4.1pp

Eastman Chemical Company's gross margin was 22.3% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.5 percentage points.

Net Margin

7.3%

YoY+1.2pp

QoQ+2.4pp

5Y change+12.8pp

10Y change-3.8pp

Eastman Chemical Company's net profit margin was 7.3% in Q2 2026, showing the share of revenue converted to profit. This is up 1.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.4 percentage points.

Return on Equity

3.0%

YoY+0.6pp

QoQ+1.2pp

5Y change+5.5pp

10Y change-2.8pp

Eastman Chemical Company's ROE was 3.0% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.2 percentage points.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

R&D Spending

$65.0M

YoY-3.0%

QoQ+8.3%

Eastman Chemical Company invested $65.0M in research and development in Q2 2026. This represents a decrease of 3.0% from the same quarter a year earlier. Against the prior quarter it is up 8.3%.

Capital Expenditures

$100.0M

YoY-33.3%

QoQ-2.9%

5Y CAGR-1.3%

10Y CAGR-2.1%

Eastman Chemical Company invested $100.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 33.3% from the same quarter a year earlier. Against the prior quarter it is down 2.9%.

Share Buybacks

Not reported for Q2 2026.

EMN Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EMN quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$8.9B	$8.8B-6.7%	$9.4B+1.9%	$9.2B-12.9%	$10.6B+1.0%	$10.5B+23.6%	$8.5B-8.6%	$9.3B-8.6%	$10.2B+6.3%	$9.5B+6.0%	$9.0B-6.6%	$9.6B+1.3%	$9.5B+1.9%	$9.3B+15.4%	$8.1B+12.9%	$7.2B
Cost of Revenue	$7.1B	$6.9B-2.6%	$7.1B-0.8%	$7.1B-15.3%	$8.4B+5.9%	$8.0B+22.7%	$6.5B-7.7%	$7.0B-8.3%	$7.7B+6.8%	$7.2B+8.0%	$6.7B-5.9%	$7.1B-3.3%	$7.3B+11.1%	$6.6B+3.7%	$6.3B+13.0%	$5.6B
Gross Profit	$1.8B	$1.8B-19.5%	$2.3B+11.1%	$2.1B-3.6%	$2.1B-14.5%	$2.5B+26.6%	$2.0B-11.6%	$2.2B-9.9%	$2.5B+4.9%	$2.4B+0.3%	$2.4B-8.6%	$2.6B+16.2%	$2.2B-20.0%	$2.8B+57.5%	$1.8B+12.3%	$1.6B
R&D Expenses	$246.0M	$255.0M+2.0%	$250.0M+4.6%	$239.0M-9.5%	$264.0M+3.9%	$254.0M+12.4%	$226.0M-3.4%	$234.0M-0.4%	$235.0M+3.5%	$227.0M+1.8%	$223.0M-7.9%	$242.0M+6.6%	$227.0M+17.6%	$193.0M-2.5%	$198.0M+24.5%	$159.0M
SG&A Expenses	$682.0M	$658.0M-10.6%	$736.0M+1.2%	$727.0M+0.1%	$726.0M-8.7%	$795.0M+21.6%	$654.0M-5.4%	$691.0M-4.2%	$721.0M-1.1%	$729.0M+3.1%	$707.0M-8.3%	$771.0M+2.1%	$755.0M+17.1%	$645.0M+0.2%	$644.0M+33.9%	$481.0M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$1.5B+10.8%	$1.4B-0.1%	$1.4B+19.1%	$1.2B-37.6%	$1.9B+132.8%	$800.0M-14.6%	$937.0M
EBITDA	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$2.1B+7.9%	$2.0B+0.4%	$2.0B+21.3%	$1.6B-29.8%	$2.3B+97.8%	$1.2B-4.1%	$1.2B
Interest Expense	-$213.0M	-$208.0M-4.0%	-$200.0M+7.0%	-$215.0M-18.1%	-$182.0M+8.1%	-$198.0M+5.7%	-$210.0M+3.7%	-$218.0M+7.2%	-$235.0M+2.5%	-$241.0M+5.5%	-$255.0M+3.0%	-$263.0M-40.6%	-$187.0M-3.9%	-$180.0M-25.9%	-$143.0M-88.2%	-$76.0M
Income Tax	$95.0M	$93.0M-45.3%	$170.0M-11.0%	$191.0M+5.5%	$181.0M-15.8%	$215.0M+424.4%	$41.0M-70.7%	$140.0M-38.1%	$226.0M+328.3%	-$99.0M-152.1%	$190.0M-30.9%	$275.0M+17.0%	$235.0M-53.6%	$507.0M+146.1%	$206.0M-24.8%	$274.0M
Net Income	$442.0M	$474.0M-47.6%	$905.0M+1.2%	$894.0M+12.7%	$793.0M-7.5%	$857.0M+79.3%	$478.0M-37.0%	$759.0M-29.7%	$1.1B-22.0%	$1.4B+62.1%	$854.0M+0.7%	$848.0M+12.9%	$751.0M-35.5%	$1.2B+166.6%	$437.0M-32.4%	$646.0M
EPS (Basic)	N/A	$4.14-46.6%	$7.75+2.8%	$7.54+17.4%	$6.42+1.1%	$6.35+79.9%	$3.53-36.1%	$5.52-27.8%	$7.65-20.0%	$9.56+64.8%	$5.80+1.6%	$5.71+13.5%	$5.03-33.6%	$7.57+152.3%	$3.00-35.2%	$4.63
EPS (Diluted)	$3.84	$4.10-46.5%	$7.67+2.4%	$7.49+18.0%	$6.35+1.6%	$6.25+78.6%	$3.50-36.1%	$5.48-27.5%	$7.56-20.2%	$9.47+64.7%	$5.75+1.6%	$5.66+13.9%	$4.97-33.2%	$7.44+153.9%	$2.93-35.2%	$4.52
Diluted Shares (Avg)	N/A	116M-2.0%	118M-1.3%	119M-4.4%	125M-8.9%	137M+0.4%	137M-1.4%	139M-3.1%	143M-2.2%	146M-1.5%	148M-0.9%	150M-0.9%	151M-3.5%	157M+5.0%	149M+4.2%	143M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$2.5B+9.9%	$2.2B-4.9%	$2.0B-12.1%	$2.2B-10.6%	$2.3B-3.2%	$2.3B-0.9%	$2.2B+1.7%	$2.5B+8.7%
Cost of Revenue	$2.0B+9.7%	$1.7B+1.3%	$1.6B-3.3%	$1.8B-4.8%	$1.8B+1.0%	$1.7B-3.1%	$1.7B-3.0%	$1.9B+4.3%
Gross Profit	$560.0M+10.7%	$431.0M-24.0%	$338.0M-39.0%	$433.0M-28.4%	$506.0M-15.5%	$567.0M+6.6%	$554.0M+19.4%	$605.0M+25.0%
R&D Expenses	$65.0M-3.0%	$60.0M-10.4%	$58.0M-12.1%	$63.0M-3.1%	$67.0M+11.7%	$67.0M+13.6%	$66.0M+15.8%	$65.0M+8.3%
SG&A Expenses	$185.0M+17.8%	$178.0M-2.2%	$159.0M-12.6%	$160.0M-12.6%	$157.0M-12.8%	$182.0M-4.7%	$182.0M-4.7%	$183.0M+14.4%
Interest Expense	-$55.0M-3.8%	-$52.0M-6.1%	-$52.0M0.0%	-$54.0M-10.2%	-$53.0M-6.0%	-$49.0M0.0%	-$52.0M0.0%	-$49.0M+14.0%
Income Tax	$72.0M+148.3%	$29.0M-58.6%	-$93.0M-173.5%	$87.0M-12.1%	$29.0M-48.2%	$70.0M+42.9%	-$34.0M-129.8%	$99.0M+395.0%
Net Income	$183.0M+30.7%	$107.0M-41.2%	$105.0M-68.2%	$47.0M-73.9%	$140.0M-39.1%	$182.0M+10.3%	$330.0M+6.5%	$180.0M+1.1%
EPS (Basic)	$1.60+31.1%	$0.93-41.1%	$0.93-67.3%	$0.41-73.5%	$1.22-37.8%	$1.58+12.9%	$2.84+8.4%	$1.55+3.3%
EPS (Diluted)	$1.59+32.5%	$0.93-40.8%	$0.92-67.3%	$0.40-73.9%	$1.20-38.1%	$1.57+12.9%	$2.81+8.1%	$1.53+2.7%
Diluted Shares (Avg)	115M-0.8%	115M-1.3%	N/A	115M-2.0%	116M-2.0%	117M-1.4%	N/A	118M-1.0%

Not reported in any period shown, so not listed: Operating Income, EBITDA.

EMN Balance Sheet

EMN quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$14.9B-2.3%	$15.2B+4.0%	$14.6B-0.2%	$14.7B-5.5%	$15.5B-3.5%	$16.1B+0.5%	$16.0B+0.1%	$16.0B0.0%	$16.0B+3.5%	$15.5B-0.8%	$15.6B-3.1%	$16.1B+35.7%	$11.8B+1.2%	$11.7B+89.4%	$6.2B
Current Assets	$3.6B-11.1%	$4.1B+17.8%	$3.5B-7.9%	$3.8B-18.7%	$4.6B+31.2%	$3.5B+6.6%	$3.3B-1.3%	$3.4B+7.1%	$3.1B+9.7%	$2.9B-0.4%	$2.9B-9.3%	$3.2B+11.7%	$2.8B+5.2%	$2.7B+17.2%	$2.3B
Cash & Equivalents	$566.0M-32.4%	$837.0M+52.7%	$548.0M+11.2%	$493.0M+7.4%	$459.0M-18.6%	$564.0M+176.5%	$204.0M-9.7%	$226.0M+18.3%	$191.0M+5.5%	$181.0M-38.2%	$293.0M+36.9%	$214.0M-9.7%	$237.0M-4.8%	$249.0M-56.8%	$577.0M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0-100.0%	$200.0M
Inventory	$2.0B-0.4%	$2.0B+18.1%	$1.7B-11.1%	$1.9B+25.9%	$1.5B+9.1%	$1.4B-17.0%	$1.7B+5.0%	$1.6B+4.9%	$1.5B+7.5%	$1.4B-5.1%	$1.5B-2.0%	$1.5B+19.4%	$1.3B+0.3%	$1.3B+61.7%	$779.0M
Accounts Receivable	$737.0M-6.8%	$791.0M-4.2%	$826.0M-13.7%	$957.0M-12.3%	$1.1B+5.6%	$1.0B+5.4%	$980.0M-15.1%	$1.2B+12.5%	$1.0B+26.4%	$812.0M+2.5%	$792.0M-15.4%	$936.0M+6.4%	$880.0M+4.0%	$846.0M+33.9%	$632.0M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$3.7B+0.9%	$3.6B-0.4%	$3.6B-0.5%	$3.7B+0.6%	$3.6B-18.5%	$4.5B+0.8%	$4.4B-0.8%	$4.5B-1.3%	$4.5B+1.5%	$4.5B-1.3%	$4.5B+0.7%	$4.5B+70.1%	$2.6B-0.3%	$2.6B+551.2%	$406.0M
Total Liabilities	$8.8B-5.8%	$9.4B+2.8%	$9.1B-3.5%	$9.4B-3.1%	$9.7B-2.4%	$10.0B0.0%	$10.0B-1.4%	$10.1B-3.8%	$10.5B-3.0%	$10.8B-6.1%	$11.6B-7.4%	$12.5B+56.6%	$8.0B-8.2%	$8.7B+102.7%	$4.3B
Current Liabilities	$2.7B-2.1%	$2.7B+5.1%	$2.6B-20.8%	$3.3B+9.4%	$3.0B+45.8%	$2.0B+13.9%	$1.8B-3.3%	$1.9B-6.6%	$2.0B+10.4%	$1.8B-12.7%	$2.1B+1.7%	$2.0B+37.6%	$1.5B+7.8%	$1.4B+22.4%	$1.1B
Non-Current Liabilities	$6.2B-7.3%	$6.7B+1.9%	$6.5B+5.6%	$6.2B-8.6%	$6.8B-14.8%	$7.9B-3.1%	$8.2B-1.0%	$8.3B-3.2%	$8.5B-5.7%	$9.1B-4.7%	$9.5B-9.1%	$10.5B+60.9%	$6.5B-11.2%	$7.3B+130.9%	$3.2B
Long-Term Debt	$4.2B-8.0%	$4.6B+6.1%	$4.3B+7.0%	$4.0B-8.8%	$4.4B-16.3%	$5.3B-6.1%	$5.6B-5.3%	$5.9B-3.6%	$6.1B-2.6%	$6.3B-4.0%	$6.6B-9.3%	$7.2B+70.4%	$4.3B-11.0%	$4.8B+230.7%	$1.4B
Total Equity	$6.0B+3.1%	$5.8B+5.9%	$5.5B+5.9%	$5.2B-9.7%	$5.7B-5.3%	$6.0B+1.1%	$6.0B+2.7%	$5.8B+7.4%	$5.4B+19.2%	$4.5B+15.0%	$3.9B+12.3%	$3.5B-7.5%	$3.8B+29.0%	$2.9B+57.4%	$1.9B
Retained Earnings	$10.1B+0.9%	$10.0B+5.5%	$9.5B+5.8%	$9.0B+4.9%	$8.6B+5.9%	$8.1B+1.4%	$8.0B+5.2%	$7.6B+11.3%	$6.8B+18.9%	$5.7B+11.2%	$5.1B+13.2%	$4.5B+13.3%	$4.0B+32.1%	$3.0B+10.1%	$2.8B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$15.4B+1.3%	$15.2B+1.7%	$14.9B-2.3%	$15.0B-0.5%	$15.2B+1.8%	$15.0B+1.5%	$15.2B+4.0%	$15.1B+3.2%
Current Assets	$4.3B+5.8%	$4.1B+4.0%	$3.6B-11.1%	$3.8B-3.8%	$4.0B+4.7%	$3.9B+7.2%	$4.1B+17.8%	$3.9B+10.4%
Cash & Equivalents	$691.0M+63.4%	$665.0M+59.1%	$566.0M-32.4%	$489.0M-21.4%	$423.0M-17.7%	$418.0M-16.2%	$837.0M+52.7%	$622.0M+41.7%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$2.1B-2.3%	$2.1B-1.8%	$2.0B-0.4%	$1.9B+1.7%	$2.2B+13.2%	$2.1B+19.6%	$2.0B+18.1%	$1.9B+10.6%
Accounts Receivable	$1.1B+11.0%	$949.0M+6.2%	$737.0M-6.8%	$933.0M-4.8%	$988.0M+3.2%	$894.0M-3.5%	$791.0M-4.2%	$980.0M+11.4%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$3.7B-0.1%	$3.7B+0.5%	$3.7B+0.9%	N/A	$3.7B+0.7%	$3.6B-0.1%	$3.6B-0.4%	$3.7B+0.3%
Total Liabilities	$9.2B-0.7%	$9.1B+1.2%	$8.8B-5.8%	$9.1B-2.1%	$9.3B+0.7%	$9.0B-1.2%	$9.4B+2.8%	$9.3B+1.8%
Current Liabilities	$2.8B+19.0%	$2.8B+22.0%	$2.7B-2.1%	$2.2B-16.8%	$2.4B-12.9%	$2.3B-13.3%	$2.7B+5.1%	$2.6B-1.0%
Non-Current Liabilities	$6.4B-7.5%	$6.4B-5.8%	$6.2B-7.3%	$7.0B+3.5%	$6.9B+6.5%	$6.8B+3.6%	$6.7B+1.9%	$6.7B+2.9%
Long-Term Debt	$4.5B-6.9%	$4.5B-6.0%	$4.2B-8.0%	$4.8B+3.9%	$4.8B+10.3%	$4.7B+9.1%	$4.6B+6.1%	$4.6B+0.6%
Total Equity	$6.1B+4.5%	$6.0B+2.4%	$6.0B+3.1%	$5.8B+2.1%	$5.8B+3.7%	$5.9B+6.0%	$5.8B+5.9%	$5.7B+5.6%
Retained Earnings	$10.2B+0.6%	$10.1B+0.1%	$10.1B+0.9%	$10.1B+3.2%	$10.1B+4.6%	$10.1B+5.6%	$10.0B+5.5%	$9.8B+5.5%

EMN Cash Flow Statement

EMN quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$991.0M	$970.0M-24.6%	$1.3B-6.3%	$1.4B+40.9%	$975.0M-39.8%	$1.6B+11.3%	$1.5B-3.3%	$1.5B-2.5%	$1.5B-6.9%	$1.7B+19.6%	$1.4B-14.7%	$1.6B+13.3%	$1.4B+10.5%	$1.3B+15.0%	$1.1B+80.5%	$625.0M
Depreciation & Amortization	N/A	$513.0M+0.8%	$509.0M+2.2%	$498.0M+4.4%	$477.0M-11.3%	$538.0M-6.3%	$574.0M-6.1%	$611.0M+1.2%	$604.0M+2.9%	$587.0M+1.2%	$580.0M+1.6%	$571.0M+26.9%	$450.0M+3.9%	$433.0M+20.3%	$360.0M+31.9%	$273.0M
Stock-Based Compensation	N/A	$48.0M-23.8%	$63.0M-1.6%	$64.0M-7.2%	$69.0M-1.4%	$70.0M+59.1%	$44.0M-25.4%	$59.0M-7.8%	$64.0M+23.1%	$52.0M+44.4%	$36.0M0.0%	$36.0M+28.6%	$28.0M-30.0%	$40.0M+42.9%	$28.0M-28.2%	$39.0M
Capital Expenditures	$452.0M	$546.0M-8.8%	$599.0M-27.7%	$828.0M+35.5%	$611.0M+10.1%	$555.0M+44.9%	$383.0M-9.9%	$425.0M-19.5%	$528.0M-18.6%	$649.0M+3.7%	$626.0M-4.0%	$652.0M+9.9%	$593.0M+22.8%	$483.0M+3.9%	$465.0M+1.8%	$457.0M
Free Cash Flow	$539.0M	$424.0M-38.4%	$688.0M+26.0%	$546.0M+50.0%	$364.0M-65.8%	$1.1B-0.7%	$1.1B-0.6%	$1.1B+6.3%	$1.0B+0.7%	$1.0B+32.8%	$759.0M-21.9%	$972.0M+15.7%	$840.0M+3.2%	$814.0M+22.8%	$663.0M+294.6%	$168.0M
Investing Cash Flow	-$387.0M	-$462.0M+13.5%	-$534.0M-23.6%	-$432.0M-210.2%	$392.0M+1451.7%	-$29.0M+92.6%	-$394.0M+17.9%	-$480.0M-3.7%	-$463.0M+28.0%	-$643.0M+1.8%	-$655.0M+5.5%	-$693.0M+83.1%	-$4.1B-795.2%	-$457.0M+84.6%	-$3.0B-1985.9%	-$142.0M
Financing Cash Flow	-$342.0M	-$797.0M-75.6%	-$454.0M+48.9%	-$888.0M+32.8%	-$1.3B+21.8%	-$1.7B-140.1%	-$704.0M+32.5%	-$1.0B-0.3%	-$1.0B-3.4%	-$1.0B-20.0%	-$838.0M+0.7%	-$844.0M-132.0%	$2.6B+407.2%	-$859.0M-157.1%	$1.5B+455.6%	-$423.0M
Dividends Paid	$382.0M	$381.0M+0.5%	$379.0M+0.8%	$376.0M-1.3%	$381.0M+1.6%	$375.0M+4.7%	$358.0M+4.4%	$343.0M+7.9%	$318.0M+7.4%	$296.0M+8.8%	$272.0M+14.3%	$238.0M+13.3%	$210.0M+50.0%	$140.0M-27.1%	$192.0M+41.2%	$136.0M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	$900.0M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$224.0M-3.9%	-$137.0M+18.0%	$502.0M-7.0%	$402.0M+1.5%	$233.0M-36.5%	-$167.0M-943.8%	$540.0M+19.5%	$396.0M-23.0%
Depreciation & Amortization	$132.0M+3.9%	$131.0M+4.0%	$131.0M+1.6%	$129.0M+1.6%	$127.0M+0.8%	$126.0M-0.8%	$129.0M+9.3%	$127.0M+5.8%
Stock-Based Compensation	$19.0M+850.0%	$27.0M+17.4%	N/A	$13.0M-7.1%	$2.0M-85.7%	$23.0M+9.5%	N/A	$14.0M+40.0%
Capital Expenditures	$100.0M-33.3%	$103.0M-29.9%	$112.0M-37.4%	$137.0M+14.2%	$150.0M+30.4%	$147.0M-20.5%	$179.0M0.0%	$120.0M-49.2%
Free Cash Flow	$124.0M+49.4%	-$240.0M+23.6%	$390.0M+8.0%	$265.0M-4.0%	$83.0M-67.1%	-$314.0M-56.2%	$361.0M+32.2%	$276.0M-0.7%
Investing Cash Flow	-$99.0M+32.7%	-$104.0M+20.6%	-$47.0M+64.4%	-$137.0M-34.3%	-$147.0M-21.5%	-$131.0M+26.8%	-$132.0M-153.2%	-$102.0M+44.0%
Financing Cash Flow	-$100.0M-11.1%	$341.0M+375.0%	-$382.0M-111.0%	-$201.0M-3.6%	-$90.0M+60.4%	-$124.0M-183.8%	-$181.0M+69.5%	-$194.0M+35.1%
Dividends Paid	$96.0M+1.1%	$96.0M0.0%	$94.0M0.0%	$96.0M+1.1%	$95.0M0.0%	$96.0M+1.1%	$94.0M0.0%	$95.0M+1.1%

Not reported in any period shown, so not listed: Share Buybacks.

EMN Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EMN quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	21.1%-3.3pp	24.4%+2.0pp	22.4%+2.2pp	20.2%-3.7pp	23.9%+0.6pp	23.3%-0.8pp	24.1%-0.3pp	24.4%-0.3pp	24.8%-1.4pp	26.2%-0.6pp	26.7%+3.4pp	23.3%-6.4pp	29.7%+7.9pp	21.8%-0.1pp	21.9%
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	16.0%+0.7pp	15.3%+1.0pp	14.3%+2.1pp	12.2%-7.7pp	19.9%+10.0pp	9.9%-3.2pp	13.1%
Net Margin	5.4%-4.2pp	9.7%-0.1pp	9.7%+2.2pp	7.5%-0.7pp	8.2%+2.5pp	5.6%-2.6pp	8.2%-2.4pp	10.6%-3.9pp	14.5%+5.0pp	9.5%+0.7pp	8.8%+0.9pp	7.9%-4.6pp	12.5%+7.1pp	5.4%-3.6pp	9.0%
Return on Equity	8.0%-7.7pp	15.7%-0.7pp	16.4%+1.0pp	15.4%+0.4pp	15.0%+7.1pp	7.9%-4.8pp	12.7%-5.9pp	18.6%-7.0pp	25.6%+6.8pp	18.8%-2.7pp	21.5%+0.1pp	21.4%-9.3pp	30.7%+15.8pp	14.8%-19.7pp	34.5%
Return on Assets	3.2%-2.8pp	5.9%-0.2pp	6.1%+0.7pp	5.4%-0.1pp	5.5%+2.5pp	3.0%-1.8pp	4.7%-2.0pp	6.8%-1.9pp	8.6%+3.1pp	5.5%+0.1pp	5.4%+0.8pp	4.7%-5.2pp	9.8%+6.1pp	3.7%-6.7pp	10.4%
Current Ratio	1.37-0.1x	1.51+0.2x	1.35+0.2x	1.16-0.4x	1.56-0.2x	1.74-0.1x	1.860.0x	1.82+0.2x	1.590.0x	1.60+0.2x	1.40-0.2x	1.57-0.4x	1.930.0x	1.98-0.1x	2.07
Debt-to-Equity	0.70-0.1x	0.790.0x	0.790.0x	0.780.0x	0.77-0.1x	0.87-0.1x	0.94-0.1x	1.02-0.1x	1.14-0.3x	1.39-0.3x	1.67-0.4x	2.06+0.9x	1.12-0.5x	1.62+0.9x	0.77
Asset Turnover	0.590.0x	0.620.0x	0.63-0.1x	0.720.0x	0.68+0.1x	0.53-0.1x	0.58-0.1x	0.630.0x	0.600.0x	0.580.0x	0.620.0x	0.59-0.2x	0.79+0.1x	0.69-0.5x	1.16
FCF Margin	4.8%-2.5pp	7.3%+1.4pp	5.9%+2.5pp	3.4%-6.7pp	10.2%-2.5pp	12.7%+1.0pp	11.6%+1.6pp	10.0%-0.6pp	10.6%+2.1pp	8.4%-1.6pp	10.1%+1.2pp	8.8%+0.1pp	8.7%+0.5pp	8.2%+5.8pp	2.3%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	22.3%+0.2pp	19.8%-5.0pp	17.1%-7.5pp	19.7%-4.9pp	22.1%-3.2pp	24.8%+1.7pp	24.7%+3.7pp	24.6%+3.2pp
Net Margin	7.3%+1.2pp	4.9%-3.0pp	5.3%-9.4pp	2.1%-5.2pp	6.1%-3.6pp	8.0%+0.8pp	14.7%+0.6pp	7.3%-0.5pp
Return on Equity	3.0%+0.6pp	1.8%-1.3pp	1.8%-3.9pp	0.8%-2.4pp	2.4%-1.7pp	3.1%+0.1pp	5.7%0.0pp	3.2%-0.2pp
Return on Assets	1.2%+0.3pp	0.7%-0.5pp	0.7%-1.5pp	0.3%-0.9pp	0.9%-0.6pp	1.2%+0.1pp	2.2%+0.1pp	1.2%0.0pp
Current Ratio	1.50-0.2x	1.47-0.3x	1.37-0.1x	1.76+0.2x	1.68+0.3x	1.72+0.3x	1.51+0.2x	1.52+0.2x
Debt-to-Equity	0.73-0.1x	0.74-0.1x	0.70-0.1x	0.830.0x	0.820.0x	0.810.0x	0.790.0x	0.810.0x
Asset Turnover	0.160.0x	0.140.0x	0.130.0x	0.150.0x	0.150.0x	0.150.0x	0.150.0x	0.160.0x
FCF Margin	4.9%+1.3pp	-11.0%+2.7pp	19.8%+3.7pp	12.0%+0.8pp	3.6%-7.0pp	-13.7%-5.0pp	16.1%+3.7pp	11.2%-1.1pp

Not reported in any period shown, so not listed: Operating Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Eastman Chemical Company EMN	FY2025	$8.8B	$474.0M	5.4%	$7.4B	27/100
NewMarket Corporation NEU	FY2025	$2.7B	$418.7M	15.4%	$8.5B	67/100
Albemarle Corporation ALB	FY2025	$5.1B	-$510.6M	-9.9%	$12.3B	22/100
Axalta Coating Systems Ltd. AXTA	FY2025	$5.1B	$379.0M	7.4%	$6.9B	54/100
Element Solutions Inc. ESI	FY2025	$2.6B	$190.8M	7.5%	$9.2B	61/100
Balchem Corporation BCPC	FY2025	$1.0B	$154.8M	14.9%	$5.3B	58/100

Where Eastman Chemical Company Ranks

Frequently Asked Questions

What is Eastman Chemical Company's annual revenue?

Eastman Chemical Company (EMN) reported $8.8B in total revenue for fiscal year 2025. This represents a -6.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Eastman Chemical Company's revenue growing?

Eastman Chemical Company (EMN) revenue declined by 6.7% year-over-year, from $9.4B to $8.8B in fiscal year 2025.

Is Eastman Chemical Company profitable?

Yes, Eastman Chemical Company (EMN) reported a net income of $474.0M in fiscal year 2025, with a net profit margin of 5.4%.

How much debt does Eastman Chemical Company have?

As of fiscal year 2025, Eastman Chemical Company (EMN) had $566.0M in cash and equivalents against $4.2B in long-term debt.

What is Eastman Chemical Company's gross margin?

Eastman Chemical Company (EMN) had a gross margin of 21.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Eastman Chemical Company's net profit margin?

Eastman Chemical Company (EMN) had a net profit margin of 5.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Eastman Chemical Company pay dividends?

Yes, Eastman Chemical Company (EMN) paid $3.33 per share in dividends during fiscal year 2025.

What is Eastman Chemical Company's return on equity (ROE)?

Eastman Chemical Company (EMN) has a return on equity of 8.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Eastman Chemical Company's free cash flow?

Eastman Chemical Company (EMN) generated $424.0M in free cash flow during fiscal year 2025. This represents a -38.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Eastman Chemical Company's operating cash flow?

Eastman Chemical Company (EMN) generated $970.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Eastman Chemical Company's total assets?

Eastman Chemical Company (EMN) had $14.9B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Eastman Chemical Company's capital expenditures?

Eastman Chemical Company (EMN) invested $546.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Eastman Chemical Company spend on research and development?

Eastman Chemical Company (EMN) invested $255.0M in research and development during fiscal year 2025.

How many shares does Eastman Chemical Company have outstanding?

Eastman Chemical Company (EMN) had 114M shares outstanding as of fiscal year 2025.

What is Eastman Chemical Company's current ratio?

Eastman Chemical Company (EMN) had a current ratio of 1.37 as of fiscal year 2025, which is considered adequate.

What is Eastman Chemical Company's debt-to-equity ratio?

Eastman Chemical Company (EMN) had a debt-to-equity ratio of 0.70 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Eastman Chemical Company's return on assets (ROA)?

Eastman Chemical Company (EMN) had a return on assets of 3.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Eastman Chemical Company's P/E ratio?

Eastman Chemical Company (EMN) trades at 16.8x earnings, its market capitalization divided by net income of $442.0M net income, trailing 12 months to June 30, 2026. The market capitalization is $7.4B as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Eastman Chemical Company's price-to-sales ratio?

Eastman Chemical Company (EMN) trades at 0.8x sales, its market capitalization divided by revenue of $8.9B revenue, trailing 12 months to June 30, 2026. The market capitalization is $7.4B as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Eastman Chemical Company's Piotroski F-Score?

Eastman Chemical Company (EMN) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Eastman Chemical Company's earnings high quality?

Eastman Chemical Company (EMN) has an earnings quality ratio of 2.05x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Eastman Chemical Company?

Eastman Chemical Company (EMN) scores 27 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.